What is PDS Biotechnology Price-to-Free-Cash-Flow?
As of today (2024-05-23), PDS Biotechnology's share price is $3.12.
PDS Biotechnology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.94. Hence, PDS Biotechnology's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for PDS Biotechnology's Price-to-Free-Cash-Flow or its related term are showing as below:
PDSB's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.86 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -11.50% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 42.90% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 32.20% per year.
During the past 11 years, PDS Biotechnology's highest 3-Year average Free Cash Flow per Share Growth Rate was 71.60% per year. The lowest was -53.20% per year. And the median was 32.90% per year.
PDS Biotechnology Price-to-Free-Cash-Flow Historical Data
The historical data trend for PDS Biotechnology's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PDS Biotechnology's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, PDS Biotechnology's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PDS Biotechnology's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where PDS Biotechnology's Price-to-Free-Cash-Flow falls into.
PDS Biotechnology's Share Price of today is $3.12. PDS Biotechnology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
PDS Biotechnology Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of PDS Biotechnology's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
PDS Biotechnology (PDS Biotechnology) Business Description
PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PDSB has been successfully added to your 